TY  - GEN
AU  - Sahebkar,Amirhossein
AU  - Watts,Gerald F
TI  - New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?
SN  - 1573-7241
PY  - 2014///0626
KW  - Animals
KW  - Anticholesteremic Agents
KW  - therapeutic use
KW  - Apolipoproteins B
KW  - metabolism
KW  - Benzimidazoles
KW  - Cholesterol, LDL
KW  - Dyslipidemias
KW  - drug therapy
KW  - Humans
KW  - Lipid Metabolism, Inborn Errors
KW  - Lipoprotein(a)
KW  - Oligonucleotides
KW  - Proprotein Convertase 9
KW  - Proprotein Convertases
KW  - antagonists & inhibitors
KW  - Serine Endopeptidases
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/s10557-013-6479-4
ER  -